The effect of Povidone-Iodine enema in the incidence of infectious complications following prostate needle biopsy

The effect of Povidone-Iodine enema in the incidence of infectious complications following prostate needle biopsy in patients suspicious for prostate cancer and comparison with control group

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016092429935N1

Enrollment

120

Registered

2017-11-13

Start date

2017-06-07

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute prostatitis. Acute prostatitis

Interventions

Intervention 1: Rectal enema with 50 cc mixture of Povidone-Iodine and lidocaine jelly before biopsy in case group. Intervention 2: Rectal enema with 50 cc lidocaine jelly before biopsy in control gro

Prevention

Rectal enema with 50 cc mixture of Povidone-Iodine and lidocaine jelly before biopsy in case group

Rectal enema with 50 cc lidocaine jelly before biopsy in control group

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Men who refer to the Urology department of Imam Reza Hospital, Mashhad due to abnormal prostate in digital rectal exam (DRE) or increase in prostate specific antigen (PSA) for biopsy of the prostate , Obtaining informed consent Exclusion Criteria: No informed consent

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Infectious complications. Timepoint: evey week to 30 days. Method of measurement: History and Phusical exam.	—

Secondary

Measure	Time frame
Rectal Culture. Timepoint: Before and after biopsy. Method of measurement: Rectal swab.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyedalireza Ghoreifinejadian

Mashhad University of Medical Sciences

ghoreifina@mums.ac.ir+98 51 3858 3885

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026